JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 28, 2016 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,378 Total Citation Count
- Nov 30, 1979 Earliest Filing
- 104 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9028463 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle deviceMay 22, 09May 12, 15[A61K, A61B, A61M]
8759018 Method for determining treatment of disseminated intravascular coagulationFeb 18, 11Jun 24, 14[C12Q, G01N]
8283137 Process for producing recombinant fibrinogen highly producing cell and highly producing cellJul 28, 04Oct 09, 12[C12P, C12N]
8088624 Method of detecting thrombosis by measuring von Willenbrand factor-cleaving proteaseDec 22, 04Jan 03, 12[G01N]
7829306 Protein highly producing recombinant animal cell, method for preparing the same, and method for mass-producing protein using the sameOct 21, 04Nov 09, 10[C12P, C12N]
7575872 Antibody against von Willebrand factor cleaving enzyme and assay system using the sameSep 25, 03Aug 18, 09[C12N, G01N, C07K]
7572591 Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzymeMar 17, 04Aug 11, 09[A61K, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8226958 Modified SEB and prophylactics/remedies for immunopathy containing the sameExpiredMar 25, 04Jul 24, 12[A61K, C07K]
7960508 Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activityExpiredMay 10, 02Jun 14, 11[A61K, C07K]
2011/0117,602 HUMAN ANTIBODY CAPABLE OF INDUCING APOPTOSISAbandonedNov 18, 08May 19, 11[C07H, C12P, C12N, C07K]
2011/0014,193 HUMANIZED ANTI-HUMAN ALPHA 9-INTEGRIN ANTIBODYAbandonedJul 09, 09Jan 20, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2010/0120,693 MEDICAMENT FOR IMPROVING PROGNOSTIC SURVIVAL IN THERAPY OF MALIGNANT TUMORAbandonedJan 21, 10May 13, 10[A61K, A61P]
2010/0113,338 PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL/CONJUNCTIVAL DISEASEAbandonedJun 21, 06May 06, 10[A61K, A61P, C07K]
7598349 Antibodies to peptide fragments having cell death-inhibitory activityExpiredJul 21, 05Oct 06, 09[C07K]
2009/0137,001 PROCESS FOR PREPARING RECOMBINANT HUMAN THROMBIN WITH CULTURE CELLAbandonedSep 29, 06May 28, 09[C12P, C12N, C07K]
7491803 Human anti-human interleukin-18 antibody, fragment thereof and method for using sameExpiredApr 30, 04Feb 17, 09[C12N, C07K]
7484650 Sonotrode for carrying out cutting and welding operations on workpieces and method for the operation thereofExpiredDec 13, 02Feb 03, 09[B26D, B06B, B26F]
7473670 Process for producing rare earth oxide superconductorExpiredMay 06, 04Jan 06, 09[H01L, B05D]
2009/0004,673 Method for Determining Condition of Disseminated Intravascular CoagulationAbandonedJan 30, 07Jan 01, 09[C12Q, G01N]
2008/0182,791 Medicament for Improving Prognostic Survival in Therapy of Malignant TumorAbandonedFeb 22, 08Jul 31, 08[A61K, A61P]
2008/0153,132 GENETIC RECOMBINANT ECARIN AND PROCESS FOR PREPARING THE SAMEAbandonedDec 05, 07Jun 26, 08[C12P, C07K]
2008/0095,796 Novel Infectious Burasal Disease Virus And Vaccine Containing Said VirusAbandonedSep 07, 04Apr 24, 08[A61K, C07H, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.